Cor Vasa 2013, 55(4):e309-e314 | DOI: 10.1016/j.crvasa.2013.03.012

Prevalence of donor-transmitted atherosclerosis-Clinical utility of intracoronary ultrasound early after heart transplantation. A single-center study

Helena Bedáňováa,b,*, Marek Orbana,b, Martin Třetinaa, Aleš Tomášeka, Petr Malíka, Petr Filaa, Vladimír Horvátha, Jiří Ondrášeka, Radka Štěpánováb, Petr Němeca,b
a Centrum kardiovaskulární a transplantační chirurgie, Brno, Česká republika
b International Clinical Research Center, Brno, Česká republika

Introduction: Coronary allograft vasculopathy (CAV) is one of the main factors limiting long-term survival following orthotopic heart transplantation (HTx). Whether or not and, if so, how donor-transmitted atherosclerosis (DCA) affects the post-transplant course of the allograft recipient is still unclear. Conventional coronary angiography is a moderately accurate technique for DCA detection as it will reveal only the more gross morphological lesions. By contrast, intravascular ultrasound (IVUS) has been shown to be a much more sensitive technique for CAV and DCA detection. In our study we sought to determine the prevalence of DCA in our HTx patient population and identify main risk factors of DCA based on donor characteristics.

Patients and methods: We performed a retrospective analysis of data of 119 patients (92 men, 27 women) undergoing transplantation in our center from August 2006 through September 2012, who had survived their first post-transplant month and had coronary angiography and IVUS.

Results: DCA was present in 39 patients, and not documented in 80 patients. The main risk factors for DCA included donor age, cigarette smoking, and hypertension; the other parameters were not shown to be statistically significant. In-hospital mortality was low in both groups (DCA positive and DCA negative), with one patient dying in either group. One-year mortality rates post-HTx were likewise almost identical in both groups (15.4% and 15% in DCA positive and negative, respectively).

Conclusion: The prevalence of DCA in our patients was 32.8%, with major risk factors for DCA including donor age, cigarette smoking, and hypertension. As age seems to be the strongest predictor, coronary angiography should be a routine examination in individuals aged over 40 years; the examination should be considered in younger individuals with a cluster of several of risk factors. The 1-year survival in this selected patient population was identical in both groups, the implication being that the diagnosis of DCA had no effect on 1-year survival post-HTx.

Keywords: Coronary allograft vasculopathy; Donor-transmitted coronary atherosclerosis; Heart transplantation

Received: December 20, 2012; Revised: March 15, 2013; Accepted: March 21, 2013; Published: August 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bedáňová H, Orban M, Třetina M, Tomášek A, Malík P, Fila P, et al.. Prevalence of donor-transmitted atherosclerosis-Clinical utility of intracoronary ultrasound early after heart transplantation. A single-center study. Cor Vasa. 2013;55(4):e309-314. doi: 10.1016/j.crvasa.2013.03.012.
Download citation

References

  1. C. Benden, P. Aurora, L.B. Edwards, et al., The Registry of the International Society for Heart and Lung Transplantation: Fourteenth Pediatric Lung and Heart-Lung Transplantation Report-2011, Journal of Heart and Lung Transplantation 31 (10) (2012) 1045-1095. Go to original source... Go to PubMed...
  2. E.M. Tuzcu, S.R. Kapadia, E. Tutar, et al., High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound, Circulation 103 (22) (2001) 2705-2710. Go to original source... Go to PubMed...
  3. M.S. Kim, S.J. Kang, C.H.W. Lee, et al. Prevalence of coronary atherosclerosis in asymptomatic healthy subjects: an intravascular ultrasound study of donor hearts, Journal of Atherosclerosis and Thrombosis 20 (5) (2013) 465-471. Go to original source... Go to PubMed...
  4. J.A. Kobashigawa, J.M. Tobis, J.C. Starling, et al., Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years, Journal of the American College of Cardiology 45 (9) (2005) 1532-1537. Go to original source... Go to PubMed...
  5. G.S. Mintz, S.E. Nissen, W.D. Anderson, et al., American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents, Journal of the American College of Cardiology 37 (2001) 1478-1492. Go to original source... Go to PubMed...
  6. C. Di Mario, S.H. The, S. Madretsma, et al., Detection and characterization of vascular lesions by intravascular ultrasound: an in vitro study correlated with histology, Journal of the American Society of Echocardiography 5 (1992) 135-146. Go to original source... Go to PubMed...
  7. H.M. Garcia-Garcia, M.A. Costa, P.W. Serruys, Imaging of coronary atherosclerosis: intravascular ultrasound, European Heart Journal 3 (2010) 2456-2469. Go to original source... Go to PubMed...
  8. H. Li, K. Tanaka, H. Anzai, et al., Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in heart transplant recipients, Journal of the American College of Cardiology 47 (2006) 2470-2476. Go to original source... Go to PubMed...
  9. A. Konig, E. Kilian, J. Rieber, et al., Assessment of early atherosclerosis in de novo heart transplant recipients: analysis with intravascular ultrasound-derived radiofrequency analysis, Journal of Heart and Lung Transplantation 27 (1) (2008) 26-31. Go to original source... Go to PubMed...
  10. S.Z. Gao, S.A. Hunt, E.L. Alderman, et al., Relation of donor age and preexisting coronary artery disease on angiography and intracoronary ultrasound to later development of accelerated allograft coronary artery disease, Journal of the American College of Cardiology 29 (1997) 623-629. Go to original source... Go to PubMed...
  11. C.K. Wong, A.C. Yeung, The topography of intimal thickening and associated remodeling pattern of early transplant coronary disease: influence of pre-existing donor atherosclerosis, Journal of Heart and Lung Transplantation 20 (2001) 858-864. Go to original source... Go to PubMed...
  12. D. Sandler, F.N. McKenzie, A.H. Melis, et al., Early death after cardiac transplantation-the role of unsuspected donor coronary artery disease, Journal of Heart and Lung Transplantation 10 (1991) 172.
  13. M.R. Mehra, H.O. Ventura, D.D. Stapleton, et al., Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy, Journal of Heart and Lung Transplantation 14 (4) (1995) 632-639. Go to PubMed...
  14. P.R. Rickenbacher, F.J.Pinto, N.P. Lewis, et al., Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation, Circulation 92 (12) (1995) 3445-3452. Go to original source... Go to PubMed...
  15. M.R. Mehra, H.O. Ventura, P.A. Uber, et al., Is all intimal proliferation created equal in cardiac allograft vasculopathy? The quantity-quality paradox, Journal of Heart and Lung Transplantation 22 (2) (2003) 118-123. Go to original source... Go to PubMed...
  16. S.R. Kapadia, S.E. Nissen, E.M.Tuzcu, Impact of intravascular ultrasound in understanding transplant coronary artery disease, Current Opinion in Cardiology 14 (2) (1999) 140-150. Go to original source... Go to PubMed...
  17. M. Yamasaki, R. Sakurai, A. Hirohata, et al., Impact of donor-transmitted atherosclerosis on early cardiac allograft vasculopathy: new findings by free-dimensional intravascular ultrasound analysis, Transplantation 91 (2011)1406-1411. Go to original source... Go to PubMed...
  18. F.M. Sacks, M.A. Pfeffer, L.A. Moye, et al., The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators, The New England Journal of Medicine 335 (1996) 1001-1009. Go to original source... Go to PubMed...
  19. R. Nakazato, H. Gransar, D.S. Berman, et al., Statins use and coronary artery plaque composition: results from the International Multicenter CONFIRM Registry, Atherosclerosis 225 (1) (2012) 148-153. Go to original source... Go to PubMed...
  20. F. Sonntag, J.R. Schaefer, A.K. Gitt, et al., Lipid therapy in daily routine, Deutsche Medizinische Wochenschrift 137 (40) (2012) 2047-2052. Go to original source... Go to PubMed...
  21. A. Keogh, L. Simons, P. Spratt, et al., Hyperlipidemia after heart transplantation, Journal of Heart Transplantation 7 (1988) 171-175.
  22. B. Skalicka, M. Kubanek, I. Malek, et al., Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin, Journal of Heart and Lung Transplantation 28 (6) (2009) 598-604. Go to original source... Go to PubMed...
  23. M. Zakliczynski, J. Boguslawska, E. Wojniak, et al., In the era of the universal use of statins dyslipidemia's are still common in heart transplant recipients: a cross-sectional study, Transplantation Proceedings 43 (8) (2011) 3071-3073. Go to original source... Go to PubMed...
  24. A.W. Wu, C.H.M. Ballantyne, B.C. Short, et al. Statin use and risks of death or fatal rejection in the Heart transplant lipid registry, American Journal of Cardiology 95 (2005) 367-372. Go to original source... Go to PubMed...
  25. K. Wenke, B. Meiser, J. Thiery, et al., Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial, Circulation 96 (1997) 1398-1402. Go to original source... Go to PubMed...
  26. M.R. Mehra, H.O. Ventura, F.W. Smart, et al., An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy, The American Journal of Cardiology 75 (12) (1995) 853-854. Go to original source...
  27. E. Raichlin, S.S. Kushwaha, Proliferation signal inhibitors and cardiac allograft vasculopathy, Current Opinion in Organ Transplantation 13 (5) (2008) 543-550. Go to original source... Go to PubMed...
  28. S. Arora, T. Ueland, B. Wennerblom, et al., Effect of everolimus introduction on cardiac allograft vasculopathy-results of a randomized, multicenter trial, Transplantation 92 (2) (2011) 235-243. Go to original source... Go to PubMed...
  29. N.K. Chou, C.F. Jan, N.H. Chi, et al., Cardiac allograft vasculopathy compared by intravascular ultrasound sonography: everolimus to mycophenolate mofetil-one single-center experience, Transplantation Proceedings 44 (4) (2012) 897-899. Go to original source... Go to PubMed...
  30. J.F. Delgado, N. Manito, J. Segovia, et al., The use of proliferation signal inhibitors in the prevention and treatment of allograft vasculopathy in heart transplantation, Transplantation Reviews (Orlando) 23 (2) (2009) 69-79. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.